Discloses an isolated immune system cell comprising a chimeric cytokine receptor comprising a cytokine-binding exodomain and a signal transducing endodomain, wherein (a) the exodomain comprises an IL-10 receptor exodomain, a TGFbeta receptor exodomain, an IL-6 receptor exodomain, an IL-8 receptor exodomain, or a combination thereof, and (b) the endodomain comprises an IL-2 receptor endodomain, an IL-7 receptor endodomain, an IL-15 receptor endodomain, or a combination thereof. Also discloses related methods of producing such cells and use in treating cancer.